| Hans-Günter Meyer-Thompson | Hepatitiden
Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?.
Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?.
Christensen, S., Buggisch, P., Mauss, S., Böker, K. H. W., Schott, E., Klinker, H., Zimmermann, T., Weber, B., Reimer, J., Serfert, Y., and Wedemeyer, H. (2018)
Addiction, doi: 10.1111/add.14128.
http://onlinelibrary.wiley.com/doi/10.1111/add.14128/abstract